Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,924Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1AA PHARMA INC

02 3PALADIN PHARMA INC.

03 2TEVA CANADA LIMITED

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMPHETAMINE

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 100/500

Approval Date :

Application Number : 2443236

Regulatory Info : Schedule G (CDSA I)

Registration Country : Canada

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DEXTROAMPHETAMINE SULFATE

Brand Name : TEVA-DEXTROAMPHETAMINE SR

Dosage Form : CAPSULE (SUSTAINED-RELEASE)

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 2448319

Regulatory Info : Schedule G (CDSA I)

Registration Country : Canada

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DEXTROAMPHETAMINE SULFATE

Brand Name : TEVA-DEXTROAMPHETAMINE SR

Dosage Form : CAPSULE (SUSTAINED-RELEASE)

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number : 2448327

Regulatory Info : Schedule G (CDSA I)

Registration Country : Canada

blank

04

PALADIN PHARMA INC.

Country
2024 ACI Convention
Not Confirmed
arrow

PALADIN PHARMA INC.

Country
arrow
2024 ACI Convention
Not Confirmed

DEXTROAMPHETAMINE SULFATE

Brand Name : DEXEDRINE

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 1924516

Regulatory Info : Schedule G (CDSA I)

Registration Country : Canada

blank

05

PALADIN PHARMA INC.

Country
2024 ACI Convention
Not Confirmed
arrow

PALADIN PHARMA INC.

Country
arrow
2024 ACI Convention
Not Confirmed

DEXTROAMPHETAMINE SULFATE

Brand Name : DEXEDRINE SPANSULE

Dosage Form : CAPSULE (SUSTAINED-RELEASE)

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number : 1924567

Regulatory Info : Schedule G (CDSA I)

Registration Country : Canada

blank

06

PALADIN PHARMA INC.

Country
2024 ACI Convention
Not Confirmed
arrow

PALADIN PHARMA INC.

Country
arrow
2024 ACI Convention
Not Confirmed

DEXTROAMPHETAMINE SULFATE

Brand Name : DEXEDRINE SPANSULE

Dosage Form : CAPSULE (SUSTAINED-RELEASE)

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 1924559

Regulatory Info : Schedule G (CDSA I)

Registration Country : Canada

blank